Number of the records: 1
faktor nekrotizujúci nádory, alfa
Record number d014409 Date 06.06.2025 Type M Topical term faktor nekrotizujúci nádory, alfa Other term English (Pseudonym) Cachectin
English (Pseudonym) TNF-alpha
English (Pseudonym) Tumor Necrosis Factor Ligand Superfamily Member 2
Slovak (Pseudonym) kachektín
Slovak (Pseudonym) TNF-alfa
Slovak (Pseudonym) faktor nekrotizujúci tumory, alfa
Slovak (Pseudonym) tumor nekrotizujúci faktor alfa
Slovak (Pseudonym) superrodina ligandov faktora nekrotizujúceho nádory, člen 2
See also (Later heading) nekróza
(Skutočné meno) certolizumab pegol
(Skutočné meno) adalimumab
(Skutočné meno) infliximab
(Later heading) syndróm lýzy nádoru
(Later heading) certolizumab pegol
(Later heading) adalimumab
(Later heading) infliximab
UDC D09.400.430.965D12.644.276.374.500.800D12.644.276.374.750.626D12.776.124.900D12.776.395.930D12.776.467.374.500.800D12.776.467.374.750.626D23.529.374.500.800D23.529.374.750.626 Note Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. 
subject heading
Number of the records: 1